These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9606527)

  • 1. High delta sleep-inducing peptide-like immunoreactivity in plasma in suicidal patients with major depressive disorder.
    Westrin A; Ekman R; Träskman-Bendz L
    Biol Psychiatry; 1998 May; 43(10):734-9. PubMed ID: 9606527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations between plasma-neuropeptides and temperament dimensions differ between suicidal patients and healthy controls.
    Westrin A; Engstöm G; Ekman R; Träskman-Bendz L
    J Affect Disord; 1998 Apr; 49(1):45-54. PubMed ID: 9574859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta sleep-inducing peptide response to human corticotropin-releasing hormone (CRH) in major depressive disorder. Comparison with CRH-induced corticotropin and cortisol secretion.
    Lesch KP; Widerlöv E; Ekman R; Laux G; Schulte HM; Pfüller H; Beckmann H
    Biol Psychiatry; 1988 Jun; 24(2):162-72. PubMed ID: 2839244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal rhythm of plasma delta-sleep-inducing peptide in humans: evidence for positive correlation with body temperature and negative correlation with rapid eye movement and slow wave sleep.
    Friedman TC; Garcia-Borreguero D; Hardwick D; Akuete CN; Stambuk MK; Dorn LD; Starkman MN; Loh YP; Chrousos GP
    J Clin Endocrinol Metab; 1994 May; 78(5):1085-9. PubMed ID: 8175965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased delta-sleep and plasma delta-sleep-inducing peptide in patients with Cushing syndrome.
    Friedman TC; García-Borreguero D; Hardwick D; Akuete CN; Doppman JL; Dorn LD; Barker CN; Yanovski JA; Chrousos GP
    Neuroendocrinology; 1994 Dec; 60(6):626-34. PubMed ID: 7700506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicidal intent and the HPA-axis characteristics of suicide attempters with major depressive disorder and adjustment disorders.
    Lindqvist D; Träskman-Bendz L; Vang F
    Arch Suicide Res; 2008; 12(3):197-207. PubMed ID: 18576201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior.
    Pitchot W; Scantamburlo G; Pinto E; Hansenne M; Reggers J; Ansseau M; Legros JJ
    J Psychiatr Res; 2008 Jul; 42(8):684-8. PubMed ID: 17720191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA-related CSF neuropeptides in suicide attempters.
    Träskman-Bendz L; Ekman R; Regnéll G; Ohman R
    Eur Neuropsychopharmacol; 1992 Jun; 2(2):99-106. PubMed ID: 1378770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression.
    Roy A
    Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters.
    Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å
    Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma levels of circulating cell-free mitochondrial DNA in suicide attempters: associations with HPA-axis hyperactivity.
    Lindqvist D; Fernström J; Grudet C; Ljunggren L; Träskman-Bendz L; Ohlsson L; Westrin Å
    Transl Psychiatry; 2016 Dec; 6(12):e971. PubMed ID: 27922635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients.
    Jokinen J; Nordström P
    J Affect Disord; 2009 Jul; 116(1-2):117-20. PubMed ID: 19054569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human plasma DSIP decreases at the initiation of sleep at different circadian times.
    Seifritz E; Müller MJ; Schönenberger GA; Trachsel L; Hemmeter U; Hatzinger M; Ernst A; Moore P; Holsboer-Trachsler E
    Peptides; 1995; 16(8):1475-81. PubMed ID: 8745061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal development of delta-sleep-inducing-peptide-like immunoreactivity in hypothalamus of guinea pig with special regard to the prenatal colocalization with gonadotropin-releasing-hormone-like immunoreactivity.
    Pu LP; Dubois PM
    Neuroendocrinology; 1992 Jan; 55(1):66-73. PubMed ID: 1608510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression.
    Yokoyama K; Yamada T; Mitani H; Yamada S; Pu S; Yamanashi T; Matsumura H; Nakagome K; Kaneko K
    Psychiatry Res; 2015 Apr; 226(2-3):494-8. PubMed ID: 25757913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
    Van Den Eede F; Van den Bossche B; Hulstijn W; Sabbe BG; Cosyns P; Claes SJ
    J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.